QuidelOrtho director granted 15,532 RSUs

Wilkins Joseph D Jr. reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Wilkins Joseph D Jr. reported acquisition or exercise transactions in this Form 4 filing.

QuidelOrtho Corp director receives RSU award

QuidelOrtho Corp director Joseph D. Wilkins Jr. received a grant of 15,532 restricted stock units. Each unit represents the right to receive one share of QuidelOrtho common stock if vesting conditions are met.

The restricted stock units will vest on June 25, 2027. Following this grant, Wilkins holds 15,532 RSUs directly, giving him a future equity stake tied to the company’s share performance once the award vests.

Insider Trade Summary

Grant/Award: 15,532 shares

Grant/Award 1 txn

Insider Wilkins Joseph D Jr.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units (Equity Grant)	15,532	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units (Equity Grant) — 15,532 contracts (Direct)

Footnotes (2)

1. F1. Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
2. F2. The restricted stock units will vest on June 25, 2027.

Key Figures

RSUs granted: 15,532 units RSUs after transaction: 15,532 units Vesting date: June 25, 2027 +1 more

4 metrics

RSUs granted 15,532 units Restricted stock units granted to director on June 25, 2026

RSUs after transaction 15,532 units Total RSU holdings following grant

Vesting date June 25, 2027 RSUs vesting schedule

Underlying shares 15,532 shares Common stock issuable upon RSU vesting

Key Terms

Restricted Stock Units, vest, common stock

3 terms

Restricted Stock Units financial

"Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

vest financial

"The restricted stock units will vest on June 25, 2027."

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

common stock financial

"Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock."

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did QuidelOrtho Corp (QDEL) report for Joseph D. Wilkins Jr.?

QuidelOrtho reported that director Joseph D. Wilkins Jr. received a grant of 15,532 restricted stock units. These RSUs are a form of equity compensation and each unit represents the right to receive one share of QuidelOrtho common stock if vesting conditions are met.

How many restricted stock units were granted to the QuidelOrtho (QDEL) director?

The director received 15,532 restricted stock units. This full amount also represents his total RSU holdings after the transaction, giving him a direct, equity-linked incentive that will convert into common shares if the award ultimately vests as scheduled.

When do the newly granted QuidelOrtho (QDEL) restricted stock units vest?

The restricted stock units granted to the director will vest on June 25, 2027. Vesting means the units convert into the right to receive QuidelOrtho common shares, aligning the director’s compensation with the company’s long-term share performance through that date.

What does each QuidelOrtho (QDEL) restricted stock unit represent in this Form 4?

Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. The units do not become actual shares until they vest, so this award provides future equity exposure rather than an immediate increase in freely tradable common shares.

Is the QuidelOrtho (QDEL) Form 4 transaction a market purchase or sale?

This Form 4 reports a grant or award acquisition, not a market purchase or sale. The director received 15,532 restricted stock units as compensation, with no cash price per unit, and the units will vest on June 25, 2027 rather than being bought or sold on the market.

How many QuidelOrtho (QDEL) RSUs does the director hold after this grant?

After this grant, the director holds 15,532 restricted stock units directly. This figure matches the number of RSUs awarded in the transaction, indicating this filing shows his full RSU position from this grant, subject to vesting on June 25, 2027 as disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/29/2026 - 05:59 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wilkins Joseph D Jr.

(Last) (First) (Middle)

9975 SUMMERS RIDGE ROAD

(Street)

SAN DIEGO CALIFORNIA 92121

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
QuidelOrtho Corp [ QDEL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/25/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units (Equity Grant)	(1)	06/25/2026		A		15,532		(2)	(2)	Common Stock	15,532	$0	15,532	D

Explanation of Responses:

1. Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.

2. The restricted stock units will vest on June 25, 2027.

Remarks:

	/s/ Phillip S. Askim, attorney-in-fact for Joseph D. Wilkins, Jr.	06/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)